Lonza Group AG/€LONN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Lonza Group AG
Lonza Group AG is a global company specializing in pharmaceutical, biotech, and nutrition sectors, headquartered in Basel, Switzerland. It provides integrated solutions for the creation of new drugs, ranging from active pharmaceutical ingredients (APIs) and drug formulation to drug delivery systems. The company serves a diverse clientele including pharmaceutical and biotech companies, offering contract development and manufacturing organization (CDMO) services. With operations in multiple countries, Lonza is strategically positioned to cater to global healthcare needs. Known for its extensive capabilities in cell and gene therapy, the organization leverages advanced technology platforms to support complex biopharmaceutical developments, enhancing its competitive edge in the industry.
Ticker
€LONN
Sector
Primary listing
XGAT
Employees
20,141
Headquarters
Basel, Switzerland
Website
Lonza Group AG Metrics
BasicAdvanced
€41bn
-
-€1.69
0.85
€5.47
0.46%
Price and volume
Market cap
€41bn
Beta
0.85
52-week high
€639.60
52-week low
€499.00
Average daily volume
161k
Dividend rate
€5.47
Financial strength
Current ratio
1.663
Quick ratio
0.588
Long term debt to equity
41.622
Total debt to equity
51.116
Interest coverage (TTM)
10.22%
Profitability
EBITDA (TTM)
2,568.915
Gross margin (TTM)
37.14%
Net profit margin (TTM)
-1.60%
Operating margin (TTM)
23.49%
Effective tax rate (TTM)
17.80%
Revenue per employee (TTM)
€365,450
Management effectiveness
Return on assets (TTM)
5.44%
Return on equity (TTM)
12.90%
Valuation
Price to revenue (TTM)
5.566
Price to book
4.71
Price to tangible book (TTM)
6.55
Price to free cash flow (TTM)
254.971
Free cash flow yield (TTM)
0.39%
Free cash flow per share (TTM)
2.307
Dividend yield (TTM)
0.93%
Forward dividend yield
0.46%
Growth
Revenue change (TTM)
25.91%
Earnings per share change (TTM)
-115.18%
3-year revenue growth (CAGR)
2.83%
10-year revenue growth (CAGR)
5.78%
3-year earnings per share growth (CAGR)
-53.12%
10-year earnings per share growth (CAGR)
-13.64%
3-year dividend per share growth (CAGR)
12.62%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.